Navigation Links
Pepsi Urged to Follow Example of Coca-Cola and Stop Hiding Corporate Donations
Date:4/27/2010

hy is PepsiCo hiding this information?"

PFOX is urging PepsiCo stockholders to vote for a shareholder proposal that would require Pepsi to divulge its standards for donating over $75 million in corporate assets annually to controversial groups.

"The PepsiCo Charitable Contributions Shareholder Proposal asks Pepsi to fully divulge its funding and account for how the company's charitable contributions are actually used, a reasonable request," said Quinlan.

PepsiCo manufactures Pepsi-Cola and Gatorade drinks, Frito-Lay snacks, Tropicana juices, and Quaker foods.

Parents and Friends of Ex-Gays & Gays (PFOX) leads the nation in providing outreach, education, and public awareness in support of families and the ex-gay community. To learn more, visit http://pfox.org/about_us.html

Contact:  Parents and Friends of Ex-Gays & Gays, PFOX

804-453-4737 -- PFOX@pfox.org


'/>"/>
SOURCE Parents and Friends of Ex-Gays & Gays (PFOX)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
2. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
3. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
4. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
5. Sigma-Aldrich Achieves Double Accreditation as a Certified Reference Material Producer Following ISO/IEC 17025 and ISO Guide 34
6. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
7. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
8. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
9. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
10. Study by Leading Economist Identifies Potential for $378 Billion of Savings From Follow On Biologics
11. Cardiums Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , ... July 02, 2015 , ... ... and manufacturing of surgical instruments in Orthopedics, announced today the acquisition of ... the world's largest provider of surgical instruments to the Spine Industry. The acquisition ...
(Date:7/1/2015)... AURORA, Colo. and BANGALORE, India ... a global genomic profiling company that uses next generation ... appointment of Scott A. Storrer as chief ... and CEO, he will be responsible for all strategy, ... Vijay Chandru , who has served as Strand,s chairman ...
(Date:7/1/2015)... , July 1, 2015 ... technology will ... s evidence-based clinical s olutions suite   ... technical and medical information products and services, announced today the ... clinical decision support (CDS) technology company. InferMed,s Arezzo ...
(Date:6/30/2015)... ... ... Students and faculty from Beijing City University will arrive ... an applied biotechnology course team-taught by faculty members from both institutions. The result ... universities and is taught on both continents. , “Our alliance with Beijing City ...
Breaking Biology Technology:In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 2Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4Rivier University and Beijing City University Academic and Cultural Exchanges Begin 2
... European Partnerships, ALAMEDA, Calif., and PARIS, March ... Novartis Pharma AG to give Novartis,access to Singulex,s ... Program (ETAP). Terms of the collaboration,were not disclosed. ... a,facility in Paris, France to support the needs ...
... March 6 VaxGen,Inc. (Pink Sheets: VXGN), a biopharmaceutical ... recent cash balance, with a view to,ensuring that stockholders ... the company,s proposed merger with Raven biotechnologies,inc. VaxGen,s Board ... date for the,Special Meeting of Stockholders to vote on ...
... Conference call scheduled for March 13, 2008 at 1:30 p.m. (Pacific); ... simultaneous webcast at http://www.adventrx.com , ... today announced that it will host a conference call and,webcast on ... to discuss fourth quarter and year end 2007 results. Evan M.,Levine, ...
Cached Biology Technology:Singulex Collaborates With Large Pharmaceutical Company in Erenna(TM) Technology Access Program 2VaxGen Reports Financial Update 2VaxGen Reports Financial Update 3VaxGen Reports Financial Update 4VaxGen Reports Financial Update 5VaxGen Reports Financial Update 6VaxGen Reports Financial Update 7
(Date:6/26/2015)... SPRINGVILLE, Utah , June 26, 2015 ATL ... assemblies and devices with specialties in single use solutions, headquartered ... acquisition of MedConx, Inc. (a California ... , and San Jose, Costa Rica ). ... Costa Rica with ATL Technology,s existing ...
(Date:6/24/2015)... NEW YORK , June 24, 2015 ... favorable rate. The major drivers for the market include ... increasing number of new drug launches. Over the years, ... has increased. Between 2001 and 2010, the FDA approved ... addition, according to WIPO, Europe ...
(Date:6/24/2015)... 24, 2015 Biometry authentication provider KeyLemon ... password solution one face in. ... one face in, entering the expanding biometric authentication ... multifactor-authentication biometric answer to the password problem. With ... partnership with KeyLemon, one face in allows users ...
Breaking Biology News(10 mins):ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4KeyLemon Announces Partnership With Biometric Password Solution onefacein 2
... bring forth the best properties of both ever since ... Age. In the latest successful merger, researchers at the ... of Maryland (UM) and the U.S. Food and Drug ... substances that individually have generated interest for their potential ...
... SALT LAKE CITY An international consortium of researchers ... has reported that a study of nearly 2,300 people supports ... rare genetic changes called copy number variants (CNVs). The ... the Autism Genome Project (AGP), were published in Nature on ...
... - Researchers have discovered precisely why strands of some ... stretched, findings that could be used to improve industrial ... "Any kindergartner is familiar with this beading phenomenon, which ... between your thumb and forefinger," said Osman Basaran, Purdue,s ...
Cached Biology News:Liposome-hydrogel hybrids: No toil, no trouble for stronger bubbles 2Autism genome project identifies genetic variants that may make people susceptible to disorder 2Solution to beading-saliva mystery has practical purposes 2Solution to beading-saliva mystery has practical purposes 3
Inquire...
Homogenizing Solution, 18ml Proteinase K - [50ug/l] 75 l...
Rb anti-Occludin (C-term GST)...
anti-JNK2 Immunogen: Recombinant human JNK2 protein Accession Number: NM_002752 Quality Assurance: Routinely evaluated by immunoblot. Molecular Weight: 46 and/or 54 kDa Available ...
Biology Products: